Yet, solid evidence for the oncogenic Gas6-dependent Axl signaling in HCC requires further studies in HCC patients by determining levels of sAxl and free Gas6 as well as those levels of Gas6/sAxl complexes in patient blood. The gene discussed is GAS6; the disease is hepatocellular carcinoma.